The Hub for Disease-Specific Clinical Information

Laurence Albiges, MD, PhD, and Toni K. Choueiri, MD, on RCC: Novel Combinations for Advanced Disease

Posted: Monday, June 11, 2018

Laurence Albiges, MD, PhD, of Gustave Roussy, and Toni K. Choueiri, MD, of Dana-Farber Cancer Institute, discuss a treatment study testing pegilodecakin with nivolumab or pembrolizumab in advanced renal cell carcinoma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.